A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1070 participants.

Also called NCT07527299

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,070 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07527299
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07527299. Randomized; single masking; primary purpose treatment. Start 2026-08-26 (actual); primary completion 2028-11-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
Acronym
SPAA PFA
Intervention (Device)
VARIPULSE Catheter System
Intervention (Device)
LAAO Device
Lead sponsor
Biosense Webster, Inc. (class: industry)

Record details

Record id
cardio:ct-nct07527299
Content hash
8a4572cfae5be74bc1346ff5c256f228d1de846f813ca30e404c3ee51a32a288